Genoray Co., Ltd.

Research Genoray Co., Ltd. (122310.KQ) on Bullrun: market cap KRW 41.12B, dividend yield 9.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 41.12B; dividend yield is 9.3%.

Peer valuation comparison

Latest dividend yield is 9.29% versus a Healthcare sector median of 2.4% (287.1% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 41.12Bn/a9.3%300

Dividend history

Latest trailing dividend snapshot: annual dividend/share 300 KRW, yield 9.3%.

About Genoray Co., Ltd.

Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It provides C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide. Genoray Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Genoray Co., Ltd.'s market cap?

Genoray Co., Ltd.'s market capitalization is KRW 41.12B.

Does Genoray Co., Ltd. pay a dividend?

Genoray Co., Ltd. has a dividend yield of 9.3%.

What does Genoray Co., Ltd. do?

Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It provides C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide. Genoray Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.